Common Contracts
12 similar Common Stock Sales Agreement contracts by Editas Medicine, Inc., Jounce Therapeutics, Inc., Allogene Therapeutics, Inc., others
Alpha Teknova, Inc. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • March 30th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • New York
Avidity Biosciences, Inc. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • November 8th, 2022 • Avidity Biosciences, Inc. • Pharmaceutical preparations • New York
Avidity Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
ALLOGENE THERAPEUTICS, INC. Shares of Common Stock ($0.001 par value) AMENDMENT NO. 1 TO THE SALES AGREEMENTCommon Stock Sales Agreement • November 2nd, 2022 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Reference is made to the Sales Agreement, dated November 5, 2019 (the “Agreement”), by and between Allogene Therapeutics, Inc., a Delaware corporation (the “Company”), and Cowen and Company, LLC (the “Agent”). The Company and the Agent (collectively, the “Parties”) wish to amend the Agreement, pursuant to Section 15 of the Agreement, to allow for the issuance and sale of Placement Shares under the Agreement pursuant to a new Registration Statement (as defined below) (this “Amendment”). The Parties therefore hereby agree as follows:
APPHARVEST, INC. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • August 3rd, 2022 • AppHarvest, Inc. • Agricultural production-crops • New York
AppHarvest, Inc., a Delaware public benefit corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
JOUNCE THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • November 4th, 2021 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Jounce Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
JOUNCE THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • December 17th, 2019 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Jounce Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
INVITAE CORPORATION $75,000,000 COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • February 28th, 2019 • Invitae Corp • Services-medical laboratories • New York
Invitae Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
COMMON STOCK SALES AGREEMENTCommon Stock sales Agreement • March 12th, 2018 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
Editas Medicine, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
COMMON STOCK SALES AGREEMENTCommon Stock sales Agreement • September 20th, 2017 • Corvus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Corvus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TONIX PHARMACEUTICALS HOLDING CORP. $9,000,000 COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • August 1st, 2017 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • New York
Tonix Pharmaceuticals Holding Corp. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
COMMON STOCK SALES AGREEMENTCommon Stock sales Agreement • March 3rd, 2017 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
Editas Medicine, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
CARBO CERAMICS INC. COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • July 28th, 2016 • Carbo Ceramics Inc • Abrasive, asbestos & misc nonmetallic mineral prods • New York
CARBO Ceramics Inc., a Delaware corporation (the “Company”) confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
